Injectable Glaucoma Micro-stent

Research

Minimally-invasive glaucoma surgery (MIGS) is an emerging treatment of glaucoma using tiny, microscopic-sized tubeshat, which can be inserted into the eye and drain aqueous fluid from inside to underneath the outer membrane of the eye. Glaucoma has become the second most common cause of irreversible blindness and it accounts for 12.3% (4.4 million people) of world blindness according the estimation by the World Health Organization. Current global market size of MIGS is more than 2 billion US dollars.